DSIJ Mindshare

The drug is used for overactive bladder treatment. As per IQVIA, the market for the said medicine was approx US$942.7 million in the 12-month period ending March 2019 in the US market.

Overall volumes in futures & options currently stand at 79.74 lakhs contracts with a turnover of Rs. 5,77,910.85 crore.

The company's oncology parenteral formulation plant at Baddi, Himachal Pradesh has received the US drug regulator's approval for the supply of Azacitidine injection, 100 mg/vial for the US market. Reacting to the development, the stock of Panacea Biotec was buzzing in the early morning session on Tuesday.

Overall volumes in futures & options currently stand at 79.74 lakhs contracts with a turnover of Rs. 5,77,910.85 crore.

The stock of Heidelbergcement India Limited gives consolidation breakout on the daily scale along with robust volumes. Additionally, the stock formed a sizeable bullish candle on the breakout day, which adds strength to the breakout.